BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3538383)

  • 1. [Idiopathic hypercalciuria--recent pathogenetic and diagnostic aspects].
    Hess B; Binswanger U
    Schweiz Med Wochenschr; 1986 Nov; 116(45):1569-75. PubMed ID: 3538383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vertebral density of hypercalciuric lithiasis. Its relation to calcium-protein intake and vitamin D metabolism].
    Lalau JD; Achard JM; Bataille P; Bergot C; Jans I; Boudailliez B; Petit J; Henon G; Westeel PF; el Esper N
    Ann Med Interne (Paris); 1992; 143(5):293-8. PubMed ID: 1482031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral calcium loading on intact PTH and calcitriol in idiopathic renal calcium stone formers and healthy controls.
    Hess B; Lippuner K; Takkinen R; Villiger L; Ackermann D; Jaeger P
    Nephrol Dial Transplant; 1995; 10(9):1614-9. PubMed ID: 8559479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acute acid loading on acid-base and calcium metabolism.
    Osther PJ
    Scand J Urol Nephrol; 2006; 40(1):35-44. PubMed ID: 16452054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on an oral calcium loading test in upper urinary tract stone formers].
    Orito M; Ohkawa M; Takemae K; Sugata T; Shimamura M; Okasho A; Hirano S; Hisazumi H
    Hinyokika Kiyo; 1984 Jun; 30(6):721-8. PubMed ID: 6485963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction.
    Evans RA; Hills E; Wong SY; Wyndham LE; Eade Y; Dunstan CR
    Q J Med; 1984; 53(209):41-53. PubMed ID: 6324269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphate metabolism and renal calcium stone disease.
    Wikström B
    Scand J Urol Nephrol Suppl; 1981; 61():1-56. PubMed ID: 6274003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors.
    Caudarella R; Vescini F; Buffa A; Sinicropi G; Rizzoli E; La Manna G; Stefoni S
    J Nephrol; 2003; 16(2):260-6. PubMed ID: 12768074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal tubular function in children with hypercalciuria].
    Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
    Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acids and idiopathic calcium nephrolithiasis.
    Baggio B; Budakovic A
    Urol Int; 2005; 75(2):97-101. PubMed ID: 16123560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary citrate, bone resorption and intestinal alkali absorption in stone formers with fasting hypercalciuria.
    Messa P; Mioni G; Paganin L; Cruciatti A; Greco PL; Turrin D
    Scanning Microsc; 1994; 8(3):531-8; discussion 538-9. PubMed ID: 7747155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence of hyperoxaluria in idiopathic calcium nephrolithiasis].
    Jaeger P; Portmann L; Bugnon JM; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1795-8. PubMed ID: 7178877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a test for the differential diagnosis of hypercalciuria.
    Fuss M; Verbeelen D; Geurts J; Simon J; Bergans A; De Backer M; Six R; Corvilain J
    Eur Urol; 1978; 4(5):325-9. PubMed ID: 213286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
    Osther PJ
    Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium metabolism in renal stone disease.
    Johansson G; Backman U; Danielson BG; Ljunghall S; Wikström B
    Invest Urol; 1980 Sep; 18(2):93-6. PubMed ID: 7410037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis and management of hypercalciuric nephrolithiasis.
    Breslau NA
    Miner Electrolyte Metab; 1994; 20(6):328-39. PubMed ID: 7783695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate metabolism in renal stone formers. (I): Indices of phosphate handling in calcium stone patients and healthy subjects.
    Wikström B; Backman U; Danielson BG; Fellström B; Hellsing K; Johansson G; Ljunghall S
    Scand J Urol Nephrol Suppl; 1981; 61():I:1-18. PubMed ID: 6947410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone involvement in idiopathic calcium lithiasis].
    Ghazali A; Bataille P; Solal MC; Marié A; Brazier M; Sebert JL; Prin L; Fournier A
    Nephrologie; 1995; 16(5):351-69. PubMed ID: 7566325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.